The aim of this trial was to determine if midwives or doctor leaders are more effective at
implementing a clinical practice guideline for oral dextrose gel to treat neonatal …

Introduction Neonatal hypoglycaemia is a common condition that can cause developmental
delay. Treatment of neonatal hypoglycaemia with oral dextrose gel has been shown to …

Aims To determine the use of oral dextrose gel to treat neonatal hypoglycaemia in New
Zealand (NZ), to identify barriers and enablers to the implementation of the guideline and to …

Aim We observed wide variation in the management of babies at risk of hypoglycaemia who
participated in the hPOD (h ypoglycaemia P revention with O ral D extrose gel) multicentre …

Methods Neonates≥ 35 weeks' gestation at birth and at risk for hypoglycaemia were
included in the study. Infants with a diagnosis of hypoglycaemia or admission to the …

Methods A Cochrane systematic review was conducted to evaluate the evidence for the oral
dextrose gel therapy. The authors included randomised and quasi-randomised studies …

Background Implementation of recommendations from clinical practice guidelines is
essential for evidence based clinical practice. However, the most effective methods of …

Aim The aim of this study was to evaluate dextrose gel in the management of neonatal
hypoglycaemia in the postnatal wards at an Australian tertiary level perinatal centre …

Background Neonatal hypoglycaemia is common, affecting up to 15% of newborns, and can
cause brain damage. Currently, there are no strategies, beyond early feeding, to prevent …

Background Neonatal hypoglycaemia is common, and a preventable cause of brain
damage. Dextrose gel is used to reverse hypoglycaemia in individuals with diabetes; …